Anticoagulation in pulmonary arterial hypertension: a decision analysis

Systemic anticoagulation may be beneficial in pulmonary arterial hypertension, but there is no randomized clinical trial data to guide therapeutic decision making, and current guidelines do not account for patient preferences or quality of life. Decision analytic models to evaluate the potential ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Jose, Arun, Eckman, Mark H., Elwing, Jean M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928543/
https://www.ncbi.nlm.nih.gov/pubmed/31903185
http://dx.doi.org/10.1177/2045894019895451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928543/
https://www.ncbi.nlm.nih.gov/pubmed/31903185
http://dx.doi.org/10.1177/2045894019895451

Ejemplares similares